FUSE MEDICAL, INC.: 10-Q filed 2013-07-15
What FUSE MEDICAL, INC. reported in its quarterly report filed 2013-07-15 (fiscal Q3 2013): 15 published measures, 39 facts as tagged in accession 0001477932-13-003184.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-07-15
- Fiscal period
- fiscal Q3 2013
- Accession
- 0001477932-13-003184 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All FUSE MEDICAL, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-05-31 | 968 | USD | |
| At 2012-08-31 | 5,524 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-05-31 | 124,210 | USD | |
| At 2012-08-31 | 49,714 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-05-31 | -123,242 | USD | |
| At 2012-08-31 | -44,190 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-05-31 | 162 | USD | |
| At 2012-08-31 | 334 | USD | |
| At 2012-05-31 | 6,235 | USD | |
| At 2011-08-31 | 53,401 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-03-01 to 2013-05-31 | -22,410 | USD | 92 |
| 2012-09-01 to 2013-05-31 | -79,052 | USD | 273 |
| 2012-03-01 to 2012-05-31 | -23,865 | USD | 92 |
| 2011-09-01 to 2012-05-31 | -75,192 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-09-01 to 2013-05-31 | -14,272 | USD | 273 |
| 2011-09-01 to 2012-05-31 | -47,166 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-09-01 to 2013-05-31 | 14,100 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-05-31 | -3,337,465 | USD | |
| At 2012-08-31 | -3,258,413 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-03-01 to 2013-05-31 | -22,182 | USD | 92 |
| 2012-09-01 to 2013-05-31 | -78,726 | USD | 273 |
| 2012-03-01 to 2012-05-31 | -23,870 | USD | 92 |
| 2011-09-01 to 2012-05-31 | -75,222 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-05-31 | 968 | USD | |
| At 2012-08-31 | 5,524 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-03-01 to 2013-05-31 | 228 | USD | 92 |
| 2012-09-01 to 2013-05-31 | 326 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-05-31 | 103,110 | USD | |
| At 2012-08-31 | 49,714 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-03-01 to 2013-05-31 | 22,182 | USD | 92 |
| 2012-09-01 to 2013-05-31 | 78,726 | USD | 273 |
| 2012-03-01 to 2012-05-31 | 23,870 | USD | 92 |
| 2011-09-01 to 2012-05-31 | 75,222 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-05-31 | 3,567,377 | shares | |
| At 2012-08-31 | 3,567,377 | shares |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-03-01 to 2013-05-31 | -228 | USD | 92 |
| 2012-09-01 to 2013-05-31 | -326 | USD | 273 |
| 2012-03-01 to 2012-05-31 | 5 | USD | 92 |
| 2011-09-01 to 2012-05-31 | 30 | USD | 274 |
Inspect the source
- Entity
- FUSE MEDICAL, INC. / CIK 0000319016
- Captured
- 2026-09-19T11:14:02.031Z
- SEC response SHA-256
13d41024642d3becfdbc15fe6e31fdae11d4fa7a32679fcba6c1a612c57d756a
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000319016.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))